Literature DB >> 21681190

Rare germline variants in regions of loss of heterozygosity may influence clinical course of hematological malignancies.

A Harutyunyan, B Gisslinger, T Klampfl, T Berg, K Bagienski, H Gisslinger, R Kralovics.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21681190     DOI： 10.1038/leu.2011.150

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Inherited predisposition to myeloproliferative neoplasms.

Authors:  Amy V Jones; Nicholas C P Cross
Journal:  Ther Adv Hematol       Date:  2013-08

2.  A3669G polymorphism of glucocorticoid receptor is a susceptibility allele for primary myelofibrosis and contributes to phenotypic diversity and blast transformation.

Authors:  Valentina Poletto; Vittorio Rosti; Laura Villani; Paolo Catarsi; Adriana Carolei; Rita Campanelli; Margherita Massa; Myriam Martinetti; Gianluca Viarengo; Alberto Malovini; Anna Rita Migliaccio; Giovanni Barosi
Journal:  Blood       Date:  2012-08-09       Impact factor: 22.113

Review 3.  Genetic and epigenetic alterations of myeloproliferative disorders.

Authors:  Jelena D Milosevic; Robert Kralovics
Journal:  Int J Hematol       Date:  2012-12-12       Impact factor: 2.490

4.  Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locus.

Authors:  A Chase; W Leung; W Tapper; A V Jones; L Knoops; C Rasi; L A Forsberg; P Guglielmelli; K Zoi; V Hall; L Chiecchio; L Eder-Azanza; C Bryant; L Lannfelt; L Docherty; H E White; J Score; D J G Mackay; A M Vannucchi; J P Dumanski; N C P Cross
Journal:  Leukemia       Date:  2015-05-20       Impact factor: 11.528

5.  β Thalassemia major due to acquired uniparental disomy in a previously healthy adolescent.

Authors:  Celeste Bento; Tabita M Maia; Jelena D Milosevic; Isabel M Carreira; Robert Kralovics; M Leticia Ribeiro
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.